Two Sigma Investments, LP A Ikido Pharma Inc. Transaction History

Two Sigma Investments, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	N/A	-4,100 Reduced 25.98%	11,679 $44,000
Q2 2023 Aug 14, 2023	SELL	N/A	-1,800 Reduced 10.24%	15,779 $59,000
Q1 2023 May 15, 2023	SELL	$3.46 - $4.07 $108,713 - $127,879	-31,420 Reduced 64.12%	17,579 $66,000
Q4 2022 Feb 14, 2023	SELL	$3.07 - $7.21 $14,109 - $33,137	-4,596 Reduced 8.58%	48,999 $160,000
Q3 2022 Nov 14, 2022	BUY	$5.6 - $7.03 $300,132 - $376,772	53,595 New	53,595 $367,000

461K

Ticker AIKI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,485,100
Market Cap $20.8M
Description
AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small mo...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.